1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Quantum Leap Acquisition Corp said the underwriters of its initial public offering fully exercised their over-allotment option, with the final 2,082,608 units closing on June 22, 2026. Total units sold rose to 23,000,000, for aggregate gross proceeds of $230 million at $10.00 per unit. The filing is an administrative update on the offering and does not change the company's business plan.
Underwriters gave notice on June 18, 2026 of their exercise of the remaining 2,082,608 over-allotment units; closing occurred June 22, 2026.
Total units sold reached 23,000,000, with aggregate gross proceeds of $230 million at $10.00 per unit.
Class A ordinary shares and warrants began separate trading on the NYSE on June 23, 2026, under the symbols QLEP and QLEP WS.
Globe Life signed a new $450 million term loan and a third amended credit agreement on June 26, 2026, with Wells Fargo replacing Bank of America as administrative agent. The filing shows the company extended its borrowing arrangements, with the term loan maturity moved to June 26, 2029 and the credit agreement maturity moved to June 26, 2031.
Term loan principal increased from $250 million to $450 million, with maturity extended from August 15, 2027 to June 26, 2029.
Credit agreement maturity extended from March 29, 2029 to June 26, 2031.
Wells Fargo, National Association replaces Bank of America, N.A. as administrative agent under both agreements.
The filing does not state the credit agreement's total commitment amount.
Moody's Ratings raised Alliance Laundry Holdings' corporate family rating to B1 from B2 and upgraded its senior secured first lien revolving credit facility and term loan to B1 from B2. The company said the upgrade reflects its deleveraging and steady growth, and that borrowing costs on its term loan will fall 25 basis points together with a prior S&P Global Ratings upgrade.
Moody's corporate family rating upgraded to B1 from B2
Senior secured first lien revolving credit facility and term loan also upgraded to B1 from B2
Term loan borrowing costs to decrease 25 basis points, per the company, reflecting this and the prior S&P Global upgrade
Andersen Tax LLC, an indirect subsidiary of Andersen Group Inc., entered into a $50.0 million asset-based revolving credit agreement with JPMorgan Chase Bank, N.A. on June 25, 2026. The facility matures three years from closing, bears interest at Term SOFR plus 175 basis points, and is guaranteed by Andersen Group Inc. and other Loan Parties, secured by a first lien on their assets. The filing does not report any change in reported revenue or earnings, but it sets new borrowing capacity and restrictions on distributions and acquisitions for the group.
$50.0 million revolving credit facility dated June 25, 2026, maturing three years from the Closing Date
Interest at Term SOFR plus 175 basis points; unused line fee of 25 basis points per annum
Springing minimum fixed charge coverage ratio of 1.00x applies if availability falls below 25% of the line cap
Domestic acquisitions limited to $25 million in total consideration; foreign acquisitions capped at $15 million per transaction and $75 million per year
Charles Schwab issued $1.0 billion of 4.603% Fixed-to-Floating Rate Senior Notes due 2029 on June 25, 2026, netting about $995.5 million after underwriting discounts, commissions and estimated expenses. The notes were sold under an existing shelf registration and a supplemental indenture dated June 29, 2026, adding long-term debt to the company's funding base.
Principal amount: $1,000,000,000 of 4.603% Fixed-to-Floating Rate Senior Notes due 2029
Net proceeds: approximately $995.5 million after underwriting discounts, commissions and estimated offering expenses
Issued June 25, 2026 under Underwriting Agreement with Citigroup Global Markets Inc. and Goldman Sachs & Co. LLC as representatives
Notes issued under Senior Indenture dated November 14, 2025 with The Bank of New York Mellon Trust Company, N.A., as trustee
Meritage Homes signed the Twelfth Amendment to its credit agreement on June 24, 2026, increasing the facility size to $980.0 million and extending maturity from July 9, 2030 to June 24, 2031. The amendment also lets the facility grow to $1.470 billion under certain conditions and revises the adjusted SOFR rate, giving the company a larger, longer-dated borrowing line.
Facility size increased to $980.0 million
Accordion feature permits an increase to $1.470 billion, subject to certain conditions
Maturity extended from July 9, 2030 to June 24, 2031
Amendment signed June 24, 2026; full terms filed as Exhibit 10.1
Midera Food Processing, a Middleby subsidiary, entered a five-year, $1.0 billion revolving credit agreement with Bank of America as administrative agent on June 29, 2026, in connection with its planned spin-off. The Borrower used borrowings and cash on hand to make a $233 million distribution to a Middleby subsidiary, and the spin-off is expected to take effect July 6, 2026, which means shareholders of Middleby will receive Midera shares and Midera will carry this new debt.
$1.0 billion facility: $750 million U.S. dollar revolver and $250 million multi-currency revolver, maturing June 29, 2031.
Before the spin-off takes effect, borrowings may not exceed $300 million; if the spin-off does not occur, commitments terminate within 15 business days.
The Borrower used borrowings and cash on hand to make a $233 million distribution to Middleby Marshall Inc., a Middleby subsidiary.
Middleby shareholders of record at 12:01 a.m. Eastern Time on July 6, 2026 are expected to receive Midera shares.
Alpex Acquisition Corp, a blank check company, closed its initial public offering of 11,500,000 units at $10.00 per unit on June 26, 2026, including full exercise of the underwriters' over-allotment option, for gross proceeds of $115,000,000. The filing says $115,000,000 was placed in a trust account, which will not be released until a business combination, a shareholder-approved redemption event, or the redemption of public shares if no combination is completed within 12 months.
IPO closed June 26, 2026: 11,500,000 units at $10.00 per unit, gross proceeds of $115,000,000, including 1,500,000 over-allotment units
Private sale of 187,500 units to Sponsor Hugreat Ltd for $1,875,000; 230,000 Class A shares issued to underwriter D. Boral Capital LLC
Three directors appointed June 25, 2026 (Joy Yi Hua, Xin Yue Jasmine Geffner, Yuanmei Ma); $115,000,000 placed in trust
Units began trading on Nasdaq under ALPXU on June 25, 2026
Philip Morris International prepaid €1.0 billion (approximately $1.1 billion), including part of the principal and accrued interest, on its 5-year tranche of a senior unsecured term loan facility on June 29, 2026. About €1.5 billion (approximately $1.7 billion) remains outstanding under that tranche, which expires June 23, 2027, so the filing shows a reduction in near-term debt rather than a change in operations.
Prepayment of €1.0 billion (approximately $1.1 billion) made June 29, 2026
Prepayment covered part of outstanding principal and accrued interest under the 5-year tranche
About €1.5 billion (approximately $1.7 billion) remains outstanding, expiring June 23, 2027
Zimmer Biomet signed a new $1.5 billion five-year unsecured revolving credit agreement and a $1.25 billion 364-day unsecured revolving credit agreement, both dated June 26, 2026, with JPMorgan Chase Bank as administrative agent. The company said the borrowings will fund general corporate purposes and terminated its two prior revolving facilities dated June 27, 2025, which had no balance outstanding. The filing describes the new facilities as financing arrangements that carry covenants, including a maximum consolidated indebtedness to EBITDA ratio of 4.5 to 1.0.
Five-year facility of $1.5 billion matures June 26, 2031, with an uncommitted feature to increase it by up to $750.0 million
364-day facility of $1.25 billion matures June 25, 2027
Both agreements require a consolidated indebtedness to EBITDA ratio of no greater than 4.5 to 1.0
Prior 2025 facilities were terminated June 26, 2026; about $0.4 million in fees were paid in cash
PVH Corp. entered into a new credit agreement dated June 24, 2026, with Bank of America, N.A. as administrative agent. The company used proceeds from a €400 million euro term loan to repay in full its existing credit agreement from December 9, 2022, which was then terminated. The new facilities mature on June 24, 2031 and give the company access to a $1.5 billion revolving credit line, adding a new debt obligation to its balance sheet.
Euro term loan A of €400 million borrowed by PVH B.V. on June 24, 2026, with the company's proceeds used to repay the 2022 credit agreement
$1.5 billion multicurrency revolving credit facility, with the company and PVH B.V. as borrowers
Both facilities mature June 24, 2031; term loan amortizes at 2.50% per year starting with the quarter ending September 30, 2026
Agreement includes a maximum net leverage ratio covenant and a change-in-control event of default
Terra Property Trust, Inc. announced the final results of its exchange offer for its unsecured 6.00% Senior Notes due June 30, 2026. Holders tendered $36,208,750 in principal, or 66.4% of the outstanding notes, as of the June 26, 2026 expiration date, and the exchange remains subject to the conditions in the prospectus.
Tendered principal: $36,208,750, or 66.4% of the outstanding 6.00% Senior Notes due June 30, 2026, as of 5:00 p.m. New York time on June 26, 2026
Offer terms: exchange for new 11.00% Senior Secured Notes due July 1, 2027 plus cash
Registration statement on Form S-4 declared effective by the SEC on June 26, 2026
Completion is subject to the conditions in the prospectus; Ladenburg Thalmann & Co. Inc. was dealer manager
Creative Realities began an underwritten public offering of common stock and pre-funded warrants on June 29, 2026, with Craig-Hallum as sole managing underwriter. The company also estimated unaudited second-quarter 2026 revenue of $21.0 million to $23.0 million and Adjusted EBITDA of $2.0 million to $2.2 million, and warned that final results may differ materially.
Underwritten offering of common stock or pre-funded warrants announced June 29, 2026; the offering is subject to market conditions and its size and terms are not final.
Underwriter has a 30-day option to buy up to an additional 12.5% of the shares offered.
Preliminary Q2 2026 estimates: revenue $21.0 million to $23.0 million; Adjusted EBITDA $2.0 million to $2.2 million, a margin of about 10.0%. Figures are unaudited and not reviewed by Grant Thornton LLP.
Net proceeds are intended for working capital, general corporate purposes, debt paydown and potential acquisitions.
Decoy Therapeutics entered into a securities purchase agreement on June 26, 2026 to sell 592,217 shares of common stock at $5.91 per share to one institutional investor, with closing expected on or about June 29, 2026. The deal also includes milestone-based warrants that could bring up to about $17.5 million more in gross proceeds if exercised, which would add to existing shareholder dilution and depends on future milestones and stockholder approval.
Expected gross proceeds of about $3.5 million before placement agent fees and offering expenses
592,217 shares priced at $5.91 per share, with pre-funded warrants available to the investor in lieu of shares
Series A, B and C milestone warrants could add up to about $17.5 million if fully exercised after milestones and stockholder approval
Placement agent Curvature Securities receives a 9.0% cash fee; a resale registration statement is due within 15 calendar days of the registration rights agreement
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.